
Please try another search
Pacific Edge Limited, a cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect, which enables the risk stratification of patients with haematuria; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Name | Age | Since | Title |
---|---|---|---|
Michael Sullivan | - | - | Member of Scientific Advisory Board |
Osamu Ogawa | 80 | - | Member of Scientific Advisory Board |
Nikola Kasabov | - | - | Member of Scientific Advisory Board |
Murray F. Brennan | 85 | - | Member of Scientific Advisory Board |
Parry Guilford | - | - | Chief Scientific Officer & Member of Scientific Advisory Board |
Bryan Raymond George Williams | 76 | 2013 | Member of Scientific Advisory Board & Independent Deputy Non-Executive Chairman |
R. Paul Spence | 68 | - | Member of Scientific Advisory Board |
Jay Raman | - | - | Member of Clinical Advisory Board |
David Levison | 65 | 2016 | Executive Chairman & President of Pacific Edge Diagnostics USA |
Anna Kate Stove | - | 2021 | Independent Non-Executive Director |
Anatole G. H. Masfen | - | 2008 | Independent Non-Executive Director |
Sarah Natalie Park | - | 2018 | Independent Non-Executive Director |
Chris J. Gallaher | - | 2016 | Independent Non-Executive Chairman of the Board |
Antony G. Barclay | - | 2022 | Independent Non-Executive Director |
Siamak Daneshmand | - | 2024 | Member of Clinical Advisory Board |
John Sfakianos | - | 2024 | Member of Clinical Advisory Board |
Kristen Scarpato | - | 2024 | Member of Clinical Advisory Board |
Katie Murray | - | 2024 | Member of Clinical Advisory Board |
Yair Lotan | - | 2024 | Member of Clinical Advisory Board |
Wade Sexton | - | 2024 | Member of Clinical Advisory Board |
Jonathan Wright | - | 2024 | Member of Clinical Advisory Board |
Dan Barocas | - | 2024 | Member of Clinical Advisory Board |
Sam Chang | - | 2024 | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review